2022
DOI: 10.1111/jgh.16018
|View full text |Cite
|
Sign up to set email alerts
|

Linked color imaging provides enhanced visibility with a high color difference in upper gastrointestinal neoplasms

Abstract: Background and Aim The aim of this post‐hoc analysis in a randomized, controlled, multicenter trial was to evaluate the visibility of upper gastrointestinal (UGI) neoplasms detected using linked color imaging (LCI) compared with those detected using white light imaging (WLI). Methods The visibility of the detected UGI neoplasm images obtained using both WLI and LCI was subjectively reviewed, and the median color difference (ΔE) between each lesion and the surrounding mucosa according to the CIE L*a*b* color sp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
7
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 19 publications
0
7
0
Order By: Relevance
“…Subsequent studies comparing LCI and WLI for the detection of neoplastic lesions also showed the superiority of LCI 7,8 . Subanalysis proved that LCI enhanced neoplastic visibility with high frequency and showed a significant color difference between neoplasms and the surrounding non‐neoplastic mucosae compared with WLI in stomach 9 . In the present study, we used data from the LCI‐FIND trial to evaluate the diagnostic performances of WLI and LCI for gastric cancer according to H. pylori infection status.…”
Section: Discussionmentioning
confidence: 85%
“…Subsequent studies comparing LCI and WLI for the detection of neoplastic lesions also showed the superiority of LCI 7,8 . Subanalysis proved that LCI enhanced neoplastic visibility with high frequency and showed a significant color difference between neoplasms and the surrounding non‐neoplastic mucosae compared with WLI in stomach 9 . In the present study, we used data from the LCI‐FIND trial to evaluate the diagnostic performances of WLI and LCI for gastric cancer according to H. pylori infection status.…”
Section: Discussionmentioning
confidence: 85%
“…To our knowledge, only a few publications describe the parameters influencing gastric neoplasm detection (eg, rate of detection of gastric subepithelial lesions and diverticula,30 photodocumentation of the ampulla,31 endoscopist BR,32 average examination time10 33 and use of IEE34 35); however, unlike the ADR in colonoscopy, these parameters are not feasible candidates of easy-to-understand performance indicator for EGD because gastric neoplasm detection has not been an identified performance measure of EGD. The minimum requirements for maintaining endoscopy quality might be defined by photodocumentation of endoscopic images, the endoscopist BR or examination time.…”
Section: Discussionmentioning
confidence: 99%
“…11,12 Recently, a multicenter, randomized controlled trial and sub-analysis studies have shown that the ability of LCI to detect neoplastic lesions in the UGI tract is superior to that of WLI. [13][14][15] There has been no direct comparison between NBI and LCI for the detection of UGI neoplasms. As NBI and LCI are used in different endoscopy systems, endoscopists can only use either of the IEE systems on one patient, regardless of whether they are able to choose an endoscopy system or not.…”
Section: Introductionmentioning
confidence: 99%
“…White light and short‐wavelength light, including 410‐nm (blue violet) light and 450‐nm (blue) light at an appropriate ratio, are simultaneously irradiated, and LCI images are captured by computerized image processing 11,12 . Recently, a multicenter, randomized controlled trial and sub‐analysis studies have shown that the ability of LCI to detect neoplastic lesions in the UGI tract is superior to that of WLI 13–15 …”
Section: Introductionmentioning
confidence: 99%